Arrowhead Reports Deep Tau Reduction in Early ARO-MAPT Study Arrowhead said ARO-MAPT reduced cerebrospinal-fluid total tau by as much as a 73%...
https://www.narrowit.com/news/arrowhead-aro-mapt-tau-reduction-healthy-volunteers-2026-10-14
#ArrowheadPharmaceuticals #ARWR #AROMAPT #RnaInterference
https://www.narrowit.com/news/arrowhead-aro-mapt-tau-reduction-healthy-volunteers-2026-10-14
#ArrowheadPharmaceuticals #ARWR #AROMAPT #RnaInterference
Arrowhead ARO-MAPT Shows Tau Biomarker Reduction | Narrowit.com
Arrowhead reported interim healthy-volunteer data showing up to 73% mean CSF total tau reduction, while clinical benefit in Alzheimer's disease remains untested.
www.narrowit.com
October 14, 2026 at 4:11 PM
Arrowhead Reports Deep Tau Reduction in Early ARO-MAPT Study Arrowhead said ARO-MAPT reduced cerebrospinal-fluid total tau by as much as a 73%...
https://www.narrowit.com/news/arrowhead-aro-mapt-tau-reduction-healthy-volunteers-2026-10-14
#ArrowheadPharmaceuticals #ARWR #AROMAPT #RnaInterference
https://www.narrowit.com/news/arrowhead-aro-mapt-tau-reduction-healthy-volunteers-2026-10-14
#ArrowheadPharmaceuticals #ARWR #AROMAPT #RnaInterference